Agreed Max. Its tanking, there's no doubt. But I really like the technology they hold and have acquired. Transgene with or without a partner will be moving TG4010 to Phase III, which will be one gigantic advert for Virax's Co-X-Gene technology. Taking the newly acquired GGTI-2418 to Phase II trials next year (i think) is also excellent progress.
At this stage, i have to ignore the big red mark on my portfolio and maybe pop this in a draw for 6-12 months. I'm confident things will turn around.
Agreed Max. Its tanking, there's no doubt. But I really like the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $46.40M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $2.318K | 83.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 504704 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 2243930 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| VHL (ASX) Chart |